Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Cordero

Showing results (41-50 of 243) with videos related to

Pageof 25
Sort By:
Revista Espanola De Cardiologia (English Ed.)|April 15, 2019
Estimated Percentage of Patients With Stable Coronary Heart Disease Candidates for PCSK9 InhibitorsAlberto Cordero, Lorenzo Fácila, Enrique Galve, et al.
Archivos De Cardiologia De Mexico|June 6, 2024
[Effectiveness of the CNIC polypill in secondary cardiovascular prevention in the subgroup of patients of the NEPTUNO study using atorvastatin doses of 20 mg]José R González-Juanatey, Alberto Cordero, Luis Masana, et al.
Applied Optics|November 22, 2016
Small petal tools performance for parabolizing optical surfacesCarlos Manuel Ortiz-Lima, Alberto Cordero-Dávila, Jorge González-García
Atherosclerosis|March 26, 2026
Intensive lipid-lowering strategies and major cardiovascular events in patients aged ≥65 years: A meta-analysis of randomized trial subgroupsArmando Oterino, Rosa Fernández Olmo, Miriam Martín Toro, et al.
International Journal of Cardiology|September 21, 2024
The CNIC polypill (Acetylsalicylic acid + Atorvastatin + Rampril) in secondary prevention of cardiovascular disease in patients with type 2 diabetes: A comparative analysis with alternative therapeutic approachesJosé R González-Juanatey, Luís Masana, Regina Dalmau, et al.
Medicina Clinica|June 23, 2005
[Myocardial infarction and subacute intrastent thrombosis in a patient with aspirin resistance]Amelia Velasco, Alberto Cordero, Elena Fernández-Jarne, et al.
Journal of the American College of Cardiology|June 9, 2018
Cost of Therapies in Acute Coronary Syndromes: A Relevant Factor Not Reflected in the TrialsIñigo Lozano, Ramon Lopez-Palop, Julio Garcia Rubio, et al.
Applied Optics|May 3, 2023
Exact formula to relate optical path differences and transversal aberration componentsAlberto Cordero-Dávila, Diego Gabriel Reyes-Olguín, Jorge González-García
Vascular Health and Risk Management|July 2, 2020
Understanding Erectile Dysfunction in Hypertensive Patients: The Need for Good Patient ManagementJorge Hernández-Cerda, Vicente Bertomeu-González, Pilar Zuazola, et al.
Revista Espanola De Cardiologia|August 16, 2011
[Does the metabolic syndrome need more descriptive studies or more evidence of its implication in secondary prevention?]Alberto Cordero, José Moreno-Arribas, Vicente Bertomeu-González, et al.
Pageof 25

Showing results (41-50 of 243) with videos related to

Sort By:
Pageof 25
Revista Espanola De Cardiologia (English Ed.)|April 15, 2019
Estimated Percentage of Patients With Stable Coronary Heart Disease Candidates for PCSK9 InhibitorsAlberto Cordero, Lorenzo Fácila, Enrique Galve, et al.
Archivos De Cardiologia De Mexico|June 6, 2024
[Effectiveness of the CNIC polypill in secondary cardiovascular prevention in the subgroup of patients of the NEPTUNO study using atorvastatin doses of 20 mg]José R González-Juanatey, Alberto Cordero, Luis Masana, et al.
Applied Optics|November 22, 2016
Small petal tools performance for parabolizing optical surfacesCarlos Manuel Ortiz-Lima, Alberto Cordero-Dávila, Jorge González-García
Atherosclerosis|March 26, 2026
Intensive lipid-lowering strategies and major cardiovascular events in patients aged ≥65 years: A meta-analysis of randomized trial subgroupsArmando Oterino, Rosa Fernández Olmo, Miriam Martín Toro, et al.
International Journal of Cardiology|September 21, 2024
The CNIC polypill (Acetylsalicylic acid + Atorvastatin + Rampril) in secondary prevention of cardiovascular disease in patients with type 2 diabetes: A comparative analysis with alternative therapeutic approachesJosé R González-Juanatey, Luís Masana, Regina Dalmau, et al.
Medicina Clinica|June 23, 2005
[Myocardial infarction and subacute intrastent thrombosis in a patient with aspirin resistance]Amelia Velasco, Alberto Cordero, Elena Fernández-Jarne, et al.
Journal of the American College of Cardiology|June 9, 2018
Cost of Therapies in Acute Coronary Syndromes: A Relevant Factor Not Reflected in the TrialsIñigo Lozano, Ramon Lopez-Palop, Julio Garcia Rubio, et al.
Applied Optics|May 3, 2023
Exact formula to relate optical path differences and transversal aberration componentsAlberto Cordero-Dávila, Diego Gabriel Reyes-Olguín, Jorge González-García
Vascular Health and Risk Management|July 2, 2020
Understanding Erectile Dysfunction in Hypertensive Patients: The Need for Good Patient ManagementJorge Hernández-Cerda, Vicente Bertomeu-González, Pilar Zuazola, et al.
Revista Espanola De Cardiologia|August 16, 2011
[Does the metabolic syndrome need more descriptive studies or more evidence of its implication in secondary prevention?]Alberto Cordero, José Moreno-Arribas, Vicente Bertomeu-González, et al.
Pageof 25